#386: The Danger of In-Home Use Medical Devices, Pt. 2

Global Medical Device Podcast · 10 Oct 2024 · 52m · Episode 386

What this episode covers

Regulatory expert Mike Drues joins host Etienne Nichols to discuss the unique challenges of in-home medical devices, focusing on labeling, usability, and cybersecurity. They argue that manufacturers must explicitly define the 'intended user' and 'intended use environment' in high-level labeling to limit unnecessary testing and ensure safety for non-clinicians. Drues highlights critical risks such as environmental variability, improper cleaning of reusable devices like CPAPs, and the need for robust post-market surveillance to track devices used outside controlled clinical settings.

Most relevant to

established companies

Topics

Mentioned

Companies
Greenlight Guru, Rook Quality Systems, Philips Respironics
Products
CPAP, EpiPen, Da Vinci surgical robot
Also
FDA

Other shows on the same ground, closest first.

  • People of Packaging · 32m

    127 - "If we do our job, no one will know" with LeRonda Perry

    LeRonda Perry, Packaging Engineering Manager at Integra Life Sciences, discusses her career path from Michigan State University’s packaging program to roles at Medtronic and DoubleCore Medical. She details the operational challenges of medical device packaging, including supply chain disruptions, the regulatory shift to EU MDR, and the difficulty of hiring qualified staff. Perry emphasizes the critical importance of usability testing in clinical settings, illustrating how effective packaging design ensures life-saving devices function without hindering surgical procedures.

  • Let's Combinate · 1h 03m

    021 - "Options" with Karandeep Singh Badwal

    Karandeep Singh Badwal, a QA/RA consultant and host of The MedTech Podcast, explains how defining 'intended use' determines whether a product is a regulated medical device or unregulated software, a critical distinction for startups. He details the specific regulatory challenges of Software as a Medical Device (SaMD), including cybersecurity, GDPR compliance, and the impact of the EU MDR on software classification. Badwal also discusses the strategic advantages for UK software companies post-Brexit, where they can still self-certify as Class 1 devices while EU counterparts face stricter notified body audits.

  • Being an Engineer · 45m

    S2E33 Custom Medical Device Manufacturing, Durability, & the Future of Med Device Tech | Mark A. Farber, MD

    Dr. Mark Farber, a vascular surgeon at the University of North Carolina and medical device consultant, discusses the challenges of developing custom medical devices for aneurysm treatment. He highlights the difficulty of predicting long-term durability in the harsh mechanical environment of the human body, noting that off-the-shelf devices only fit 25% of patients, necessitating custom manufacturing that can take months. Dr. Farber emphasizes the critical need for engineers to observe clinical procedures to understand the complex, dynamic variables of in vivo testing that lab simulations often miss.

  • Let's Combinate · 50m

    055 - "Critical Tasks and Knowledge Tasks" with Alexandra Benbadis

    Alexandra Benbadis, Usability Leader at Sanofi and former Senior Human Factors Consultant at Emergo by UL, explains the regulatory distinctions between critical and knowledge tasks in combination product human factors studies. She details how the FDA's CDRH and CDR definitions of 'harm' expand the scope of critical tasks to include compromised medical care, such as underdoses in maintenance medications, requiring rigorous residual risk commentary. Benbadis also describes the evolution of knowledge task protocols, specifically the two-part approach to evaluate Instructions for Use (IFU) findability and comprehension without requiring their use during initial open-ended questioning.

  • Product Startup · 29m

    074: Medical Device Product Development Best Practices

    Rob Crowder, Head of Product at Nutromics, explains how his team uses user journey mapping to navigate the complexities of developing medical sensor devices, specifically the Neutromics wearable patch. He details the process of validating unmet needs in high-stakes areas like therapeutic drug monitoring for vancomycin, emphasizing the need to focus on specific indications like bacteremia to ensure clinical utility and commercial viability. Crowder contrasts this rigorous MedTech evidence bar with general product development, highlighting the importance of identifying all stakeholders—patients, clinicians, and payers—early in the design phase to avoid feature creep and resource burnout.

The summary, chapters and topics are generated from the episode’s audio by this directory, not written by Global Medical Device Podcast. The episode itself belongs to its publisher.